Khokon Miah Akanda: 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke
Khokon Miah Akanda, Senior Brand Executive at Apex Pharma Limited, shared on LinkedIn:
“Major Updates in Stroke Care: 2026 AHA/ASA Guidelines Released Today
The American Heart Association and American Stroke Association have released the 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. These updates represent significant shifts in prehospital triage, thrombolytic choices, and post-procedural management.
Key Takeaways for Clinicians and Industry Leaders:
• Tenecteplase is Mainstream: The guidelines now endorse Tenecteplase (0.25 mg/kg) as a reasonable alternative to Alteplase for eligible patients within the 4.5-hour window.
• Expanded EVT Eligibility: Endovascular Thrombectomy (EVT) is now strongly recommended for select patients with large ischemic core strokes and basilar artery occlusions.
• Prehospital Triage: New emphasis on direct transport to EVT capable centers for suspected Large Vessel Occlusion (LVO), bypassing smaller centers when appropriate logistics exist.
• Pediatric Care: For the first time, guidelines include specific recommendations for endovascular treatment in children.
Management Shifts
Mild Stroke: Routine IV thrombolysis is not recommended for non-disabling deficits; Dual Antiplatelet Therapy (DAPT) is preferred.
Blood Pressure: Intensive lowering (<140 mm Hg) immediately post-reperfusion is not recommended and may be harmful.
Glycemic Control: Intensive glucose control between (80-130 mg/dL) is advised against due to hypoglycemia risk.
These guidelines push for faster, more precise interventions and open new doors for therapeutic options.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda